Abstract:6-Hydroxydopamine (6-OHDA), one of the most investigated Parkinson's disease neurotoxins, is widely used to study mechanisms of cell death in dopaminergic neurons. In the present study, we demonstrated that SCM198, a new compound based on the active component of Herba leonuri, significantly reduced 6-OHDA-induced cell death in dopaminergic SH-SY5Y cells and attenuated apomorphine-elicited rotational behavior in 6-OHDA-lesioned rats. Pretreatment with SCM198 (0.001, 0.01, 0.1, 1, and 10μM) concentration-dependently increased the cell viability as measured in MTT and LDH leakage assays compared with 6-OHDA-injured cells. Tocopherol, an antioxidant used as positive control, had similar effect at 10μM to SCM198 1μM. Furthermore, we assessed oxidative stress and subsequent apoptosis, the critical players in dopaminergic neurodegeneration, with 0.1, 1, and 10μM of SCM198 in SH-SY5Y cells exposed to 6-OHDA. Pretreatment with SCM198 significantly increased antioxidant enzyme superoxide dismutase activity, ameliorated intracellular reactive oxygen species generation, prevented the dissipation of mitochondrial membrane potential, decreased apoptotic cell death in Hoechst 33258 staining, as well as down-regulated Bax and up-regulated Bcl-2 in both mRNA and protein levels compared with 6-OHDA damaged cells. Moreover, intragastrical administration of SCM198 (18 or 60mgkg−1day−1) for 4 weeks significantly ameliorates apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats. These results support the neuroprotective effects of SCM198 against 6-OHDA-induced toxicity in vivo and in vitro with the underlying mechanisms of inhibiting oxidative stress and apoptosis. Therefore we suggest that SCM198 might provide a useful therapeutic strategy for neurodegenerative diseases such as Parkinson's disease.

Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivatives in vitro models of Parkinson's disease

Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents.

Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability.

Design, Synthesis and Biological Evaluation of Novel (e)‐hydroxystyryl Aralkyl Sulfones As Neuroprotective Agents

A Novel Synthetic Precursor of Styryl Sulfone Neuroprotective Agents Inhibits Neuroinflammatory Responses and Oxidative Stress Damage through the P38 Signaling Pathway in the Cell and Animal Model of Parkinson’s Disease

A Novel Synthetic Precursor of Styryl Sulfone Neuroprotective Agents Inhibits Neuroinflammatory Responses and Oxidative Stress Damage Through the P38 Signaling Pathway in the Cell and Animal Model of Parkinson's Disease.

Synthesis and Neuroprotective Effect of E-3,4-dihydroxy Styryl Aralkyl Ketones Derivatives Against Oxidative Stress and Inflammation.

Design, Synthesis and Pharmacological Evaluation of (E)-3,4-dihydroxy Styryl Sulfonamides Derivatives As Multifunctional Neuroprotective Agents Against Oxidative and Inflammatory Injury.

Synthesis and neuroprotective evaluation of ( E )-3,4-dihydroxystyryl p -substituted-phenethyl ketone derivatives against inflammatory and oxidative injury

Synthetic phenylethanoid glycoside derivatives as potent neuroprotective agents.

Protective Effect of Compound Formula Rehmannia Against Neurotoxicity and Apoptosis Induced by Α-Syn in in Vivo and in Vitro Models of Parkinson’s Disease

Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models

Neuroprotective Properties of Bis-Sulfonamide Derivatives Against 6-OHDA-Induced Parkinson's Model via Sirtuin 1 Activity and in silico Pharmacokinetic Properties

Sulforaphane protects against rotenone-induced neurotoxicity in vivo : Involvement of the mTOR, Nrf2 and autophagy pathways

Exploring the Therapeutic Effects of Multifunctional N -Salicylic Acid Tryptamine Derivative against Parkinson’s Disease

Synthesis and biological evaluation of aryloxyacetamide derivatives as neuroprotective agents.

Neuroprotective effect of salidroside against 6-OHDA-induced oxidative stress in PC12 cells

Synthesis and biological evaluation of scutellarein derivatives as neuroprotective agents via activating Nrf2/HO-1 pathway

Design, synthesis and pharmacological evaluation of caffeic acid phenethyl ester acylation as multifunctional neuroprotective agents against oxidative stress injury

Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study

Neuroprotective Effects of Scm198 on 6-Hydroxydopamine-induced Behavioral Deficit in Rats and Cytotoxicity in Neuronal Sh-Sy5y Cells